Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123485792 | 12348579 | 2 | F | 2016 | 20160516 | 20160509 | 20160714 | PER | US-ASTRAZENECA-2016SE47013 | ASTRAZENECA | 65.00 | YR | F | Y | 70.80000 | KG | 20160714 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123485792 | 12348579 | 1 | PS | FASLODEX | FULVESTRANT | 1 | Intramuscular | 21344 | INJECTION | ||||||||||
| 123485792 | 12348579 | 2 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 123485792 | 12348579 | 3 | C | ELQUIS | 2 | Oral | 0 | 5 | MG | BID | |||||||||
| 123485792 | 12348579 | 4 | C | AROMASIN | EXEMESTANE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 123485792 | 12348579 | 5 | C | QUINAPRIL. | QUINAPRIL | 1 | Oral | 0 | 15 | MG | QD | ||||||||
| 123485792 | 12348579 | 6 | C | ARNUITY | 2 | Respiratory (inhalation) | 0 | 100 | MG | QD | |||||||||
| 123485792 | 12348579 | 7 | C | FLONASE OTC | 2 | Nasal | AT NIGHT | 0 | |||||||||||
| 123485792 | 12348579 | 8 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 100,DAILY | 0 | ||||||||||
| 123485792 | 12348579 | 9 | C | XGEVA | DENOSUMAB | 1 | MONTHLY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123485792 | 12348579 | 1 | Breast cancer metastatic |
| 123485792 | 12348579 | 2 | Blood cholesterol increased |
| 123485792 | 12348579 | 3 | Thrombosis |
| 123485792 | 12348579 | 4 | Breast cancer |
| 123485792 | 12348579 | 5 | Hypertension |
| 123485792 | 12348579 | 6 | Asthma |
| 123485792 | 12348579 | 7 | Asthma |
| 123485792 | 12348579 | 8 | Thyroid disorder |
| 123485792 | 12348579 | 9 | Bone disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123485792 | 12348579 | Chest pain | |
| 123485792 | 12348579 | Cold sweat | |
| 123485792 | 12348579 | Injection site mass | |
| 123485792 | 12348579 | Loss of consciousness | |
| 123485792 | 12348579 | Oropharyngeal pain | |
| 123485792 | 12348579 | Pain | |
| 123485792 | 12348579 | Pleural effusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123485792 | 12348579 | 1 | 20160218 | 0 | ||
| 123485792 | 12348579 | 2 | 20160420 | 0 | ||
| 123485792 | 12348579 | 3 | 20160216 | 0 | ||
| 123485792 | 12348579 | 6 | 20150804 | 0 | ||
| 123485792 | 12348579 | 7 | 201601 | 0 | ||
| 123485792 | 12348579 | 8 | 1995 | 0 | ||
| 123485792 | 12348579 | 9 | 20160218 | 0 |